Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, advancing preclinical programs in autoimmunity, fibrosis, vascular disorders, and immuno-oncology
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, advancing preclinical programs in autoimmunity, fibrosis, vascular disorders, and immuno-oncology.